Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer
Oncology Research and Treatment · 2025
DOI: 10.1159/000549126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Research and Treatment, 2025. Verfasst von Ruth Himmelsbach und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, University of Freiburg - Medical Center, Freiburg, Germany, ruth.himmelsbach@uniklinik-freiburg.de. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lymph Node Excision, Salvage Therapy, Postoperative Complications. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
The goal of our study was to generate a standardized assessment of postoperative complications and functional results in patients undergoing salvage lymph node dissection (sLND) in a multimodal setting with prior primary therapy and possibly multiple courses of radiation due to nodal-recurrent prostate cancer. Patients and Methods: This study included 173 patients that underwent sLND between 2005 and 2019. Postoperative complications were reported according to Clavien-Dindo-Classification (CDC). Health-related quality of life (QoL) was assessed prospectively using a validated questionnaire (EORTC QLQ-C30). Postoperative urinary incontinence was quantified with the assessment of pad usage and the ICIQ-SF questionnaire.
Results
The any-grade complication rate after sLND was 67% (n = 115 patients). A total of patients (n = 42) had severe postoperative complications (CDC grade ≥IIIa). No grade V complications were reported. The number of lymph nodes removed was higher in patients with any-grade complications (median 32 versus 25, p = 0.03), while the number of lymph node metastases was higher in patients with severe complications (median 7 versus 3, p = 0.03). However, no clinical parameter was independently associated with complications. A total of 56% patients did not require any pads postoperatively. Median postoperative ICIQ-SF score was 5 and was higher in patients with any prior radiation (median 6 versus 0, p = 0.03). Radical prostatectomy as primary therapy (p = 0.01) and any prior radiation (p = 0.01) were independent predictors of any incontinence. Patients’ QoL was rated as moderate, with an impairment in QoL in 39% of the follow-up cohort.
Conclusion
SLND is a treatment option in selected patients with nodal-recurrent prostate cancer with considerable complication rates and possible functional impairments that need to be discussed with the patient when balancing the indication for this metastasis-directed treatment option.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, University of Freiburg - Medical Center, Freiburg, Germany, ruth.himmelsbach@uniklinik-freiburg.de.
- Department of Urology, Faculty of Medicine, University of Freiburg - Medical Center, Freiburg, Germany.
- Berta-Ottenstein-Program, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Radiation Oncology, Faculty of Medicine, University of Freiburg - Medical Center, Freiburg, Germany.
Zitieren
APA
Himmelsbach, R., Franz, J., Sigle, A., Weishaar, M., Lang, L., Spohn, S., Zamboglou, C., Grosu, A. L., Schultze-Seemann, W., Gratzke, C., Grabbert, M., & Jilg, C. (2025). Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer. Oncology Research and Treatment. https://doi.org/10.1159/000549126
Vancouver
Himmelsbach R, Franz J, Sigle A, Weishaar M, Lang L, Spohn S, et al. Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer. Oncology Research and Treatment. 2025. doi:10.1159/000549126
BibTeX
@article{Himmelsbach2025,
author = {Himmelsbach, Ruth and Franz, Julia and Sigle, August and Weishaar, Moritz and Lang, Larissa and Spohn, Simon and Zamboglou, Constantinos and Grosu, Anca-Ligia and Schultze-Seemann, Wolfgang and Gratzke, Christian and Grabbert, Markus and Jilg, Cordula},
title = {Adverse Effects and Functional Outcome after Salvage Lymph Node Dissection in Prostate Cancer},
journal = {Oncology Research and Treatment},
year = {2025},
doi = {10.1159/000549126}
}
EUVIMED